商品信息
联系客服
郑重提醒:
无质量问题不接受退换货,下单前请仔细核对信息。
下单后请及时联系客服核对商品价格,订单生效后再付款。
GenWay/Epstein Barr Virus (VCA) IgG/GWB-F14231/1x96 Assays
免费咨询热线
4000-520-616
Description:
| ProductName | Epstein-BarrVirus(VCA)IgGELISA. |
|---|---|
| #ofSamples | 1x96Assays |
| IntendedUse | TheEpstein-BarrVirus(EBV)IgG-ELISAisintendedforthequalitativedeterminationofIgGclassantibodiesagainstEpstein-Barrvirusviralcapsidantigen(VCA)inhumanserumorplasma(citrate). |
| Introduction | Epstein-BarrVirus(EBV)isamemberoftheherpesvirusfamily(Gammasubgroup,DNAvirusof120-200nm)andoneofthemostcommonhumanviruses.Thevirusoccursworldwide,andmostpeoplebecomeinfectedwithEBVsometimeduringtheirlives.TransmissionofthevirusisalmostimpossIBLetopreventsincemanyhealthypeoplecancarryandspreadthevirusintermittentlyforlife.InfantsbecomesusceptibletoEBVassoonasmaternalantibodyprotectiondisappears.Infectionofchildrenusuallycausesnosymptoms.Infectionduringadolescenceoryoungadulthoodcausesinfectiousmononucleosis35%to50%ofthetime. Infectiousmononucleosisisalmostneverfatal.TherearenoknownassociationsbetweenactiveEBVinfectionandproblemsduringpregnancy,suchasmiscarriagesorbirthdefects.Althoughthesymptomsofinfectiousmononucleosisusuallyresolvein1or2months,EBVremainsdormantorlatentinafewcellsinthethroatandbloodfortherestoftheperson"slife.Periodically,theviruscanreactivateandiscommonlyfoundinthesalivaofinfectedpersons.Thisreactivationusuallyoccurswithoutsymptomsofillness. EBValsoestablishesalifelongdormantinfectioninsomecellsofthebody"simmunesystem.AlateeventinaveryfewcarriersofthisvirusistheemergenceofBurkitt"slymphomaandnasopharyngealcarcinoma,butEBVisprobablynotthesolecauseofthesemalignancies. Thepresenceofvirusresp.infectionmaybeidentifiedbyPCRSEROlogy:monospottest.DetectionofantibodiesbyELISA TheoptimalcombinationofserologictestingconsistsofthetitrationoffourMarkers:IgMandIgGtotheviralcapsidantigen(VCA),IgMtotheearlyantigen,andantibodytoEBVnuclearantigen(EBNA).IgMtoVCAappearsearlyininfectionanddisappearswithin4to12weeks.IgGtoVCAappearsintheacutephase,peaksat2to4weeksafteronset,declinesslightly,andthenpersistsforlife. Ifantibodiestotheviralcapsidantigenarenotdetected,thepatientissusceptibletoEBVinfection. |
| Principlesoftheassay | ThequalitativeimmunoenzymaticdeterminationofIgG-classantibodiesagainstEpstein-BarrVirusisbasedontheELISA(Enzyme-linkedImmunosorbentAssay)technique. MicrotiterstripwellsareprecoatedwithEpstein-BarrVirusantigenstobindcorrespondingantibodiesofthespecimen.AfterwashingthewellstoremoveallunboundsamplematerialhorserADIshperoxidase(HRP)labelledanti-humanIgGconjugateisadded.ThisconjugatebindstothecapturedEpstein-BarrVirus-specificantibodies.TheimmunecomplexformedbytheboundconjugateisvisualizedbyaddingTetramethylbenzidine-(TMB)substratewhichgivesabluereactionproduct.TheintensityofthisproductisproportionaltotheamountofEpstein-BarrVirus-specificIgGantibodiesinthespecimen.Sulphuricacidisaddedtostopthereaction.Thisproducesayellowendpointcolour.Absorbanceat450nmisreadusinganELISAmicrowellplatereader. |
| StorageandStABIlity | Thereagentsarestableuptotheexpirydatestatedonthelabelwhenstoredat2-8°C. |
| LimitationsoftheTest | Bacterialcontaminationorrepeatedfreeze-thawcyclesofthespecimenmayaffecttheabsorbancevalues.Diagnosisofaninfectiousdiseaseshouldnotbeestablishedonthebasisofasingletestresult.Aprecisediagnosisshouldtakeintoconsiderationclinicalhistory,symptomatologyaswellasserologicaldata. Inimmunocompromisedpatientsandnewbornsserologicaldataonlyhaverestrictedvalue. |
| References |
|
AdditionalInformation:
| Name | EpsteinBarrVirus(VCA)IgG |
|---|---|
| RelatedProductNames | Epstein-BarrVirus(VCA)IgG–ELISA |
| MolecularWeight | 0.5 |
| Storage | Thereagentsarestableuptotheexpirydatestatedonthelabelwhenstoredat2...8°C. |
| IntendedUse | ResearchUseOnly |

